Literature DB >> 18464944

Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.

Min Cheng1, Satwat Hashmi, Xiaobo Mao, Qiu Tang Zeng.   

Abstract

OBJECTIVES: Adiponectin, an adipocyte-specific protein, matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play a crucial role in arteriosclerosis and plaque disruption. The present study was designed to elucidate the relationship of adiponectin and the ratio of MMP-9/TIMP-1 and their effects on the stability of plaque in acute coronary syndrome (ACS).
METHODS: The concentrations of adiponectin, MMP-9, TIMP-1 and interleukin-10 were analyzed using ELISA in 56 consecutive unselected patients divided into two groups, stable angina (n=13) and ACS (n=43), and were compared with 19 healthy control subjects. The 56 patients were also angiographically studied and divided into two groups, simple lesion (n=22) and complex lesion (n=34), based on coronary plaque morphology.
RESULTS: The ratio of MMP-9/TIMP-1 showed significantly higher values in the ACS group compared with the control group (0.22+/-0.10 versus 0.11+/-0.03; P<0.001). Adiponectin was negatively correlated with the ratio of MMP-9/TIMP-1 (r=--0.332; P=0.008) and positively correlated with interleukin-10 (r=0.651; P=0.001). Multivariate logistic regression analysis showed that adiponectin (P=0.046) and MMP-9/TIMP-1 (P=0.044) are independent predictors for ACS, and MMP-9/TIMP-1 (P=0.013) is an independent predictor for complex lesion morphology plaques.
CONCLUSION: In the present study, it was found that adiponectin has a negative relationship with the ratio of MMP-9/TIMP-1 in patients with ACS, and that the ratio of MMP-9/TIMP-1 is an independent predictor of the stability of atherosclerotic plaque and the severity of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18464944      PMCID: PMC2643141          DOI: 10.1016/s0828-282x(08)70602-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  31 in total

Review 1.  The role of chemokines in human cardiovascular pathology: enhanced biological insights.

Authors:  William S Shin; Andrzej Szuba; Stanley G Rockson
Journal:  Atherosclerosis       Date:  2002-01       Impact factor: 5.162

2.  Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.

Authors:  N Ouchi; S Kihara; Y Arita; M Nishida; A Matsuyama; Y Okamoto; M Ishigami; H Kuriyama; K Kishida; H Nishizawa; K Hotta; M Muraguchi; Y Ohmoto; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

3.  Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway.

Authors:  N Ouchi; S Kihara; Y Arita; Y Okamoto; K Maeda; H Kuriyama; K Hotta; M Nishida; M Takahashi; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

4.  Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.

Authors:  Samuele Nanni; Giovanni Melandri; Roeland Hanemaaijer; Vittorio Cervi; Luciana Tomasi; Annalisa Altimari; Natascha Van Lent; Pierluigi Tricoci; Letizia Bacchi; Angelo Branzi
Journal:  Transl Res       Date:  2007-03       Impact factor: 7.012

5.  Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness.

Authors:  Mahmoud Zureik; Jean-Louis Beaudeux; Dominique Courbon; Athanase Bénétos; Pierre Ducimetière
Journal:  J Hypertens       Date:  2005-12       Impact factor: 4.844

6.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

7.  Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

Authors:  Y Inokubo; H Hanada; H Ishizaka; T Fukushi; T Kamada; K Okumura
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

8.  Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss.

Authors:  M R Manigrasso; P Ferroni; F Santilli; T Taraborelli; M T Guagnano; N Michetti; G Davì
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

9.  Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.

Authors:  Yukio Arita; Shinji Kihara; Noriyuki Ouchi; Kazuhisa Maeda; Hiroshi Kuriyama; Yoshihisa Okamoto; Masahiro Kumada; Kikuko Hotta; Makoto Nishida; Masahiko Takahashi; Tadashi Nakamura; Iichiro Shimomura; Masahiro Muraguchi; Yasukazu Ohmoto; Tohru Funahashi; Yuji Matsuzawa
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

10.  Disruption of adiponectin causes insulin resistance and neointimal formation.

Authors:  Naoto Kubota; Yasuo Terauchi; Toshimasa Yamauchi; Tetsuya Kubota; Masao Moroi; Junji Matsui; Kazuhiro Eto; Tokuyuki Yamashita; Junji Kamon; Hidemi Satoh; Wataru Yano; Philippe Froguel; Ryozo Nagai; Satoshi Kimura; Takashi Kadowaki; Tetsuo Noda
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

View more
  12 in total

1.  TIMP2 gene polymorphisms are associated with hypertension in patients with myocardial infarction.

Authors:  José Manuel Rodríguez-Pérez; Nancy Martínez-Rodríguez; Gilberto Vargas-Alarcón; Maite Vallejo; Irma Eloisa Monroy-Muñoz; Carlos Posadas-Romero; Eric Kimura-Hayama; Teresa Juárez-Cedillo; José Manuel Fragoso; Nonanzit Pérez-Hernández
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

Review 2.  Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.

Authors:  Allison E Aiello; George A Kaplan
Journal:  Biodemography Soc Biol       Date:  2009

3.  Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.

Authors:  Anu Shilpa Krishnatry; Sun Mi Fung; Daniel A Brazeau; David Soda; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2010-12-13       Impact factor: 4.427

4.  Rosiglitazone modulates collagen deposition and metabolism in atherosclerotic plaques of fat-fed ApoE-knockout mice.

Authors:  Mingxue Zhou; Hao Xu; Weihong Liu; Hongxu Liu
Journal:  Exp Ther Med       Date:  2015-08-25       Impact factor: 2.447

5.  Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease.

Authors:  Rashidi Springall; Luis M Amezcua-Guerra; Hector Gonzalez-Pacheco; Janette Furuzawa-Carballeda; Lorena Gomez-Garcia; Ricardo Marquez-Velasco; Ana María Mejía-Domínguez; Jorge Cossío-Aranda; Carlos Martínez-Sánchez; Rafael Bojalil
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.

Authors:  Eline Bredal Furenes; Trine Baur Opstad; Svein Solheim; Ketil Lunde; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Mediators Inflamm       Date:  2014-09-11       Impact factor: 4.711

Review 7.  Differential effects of leptin and adiponectin in endothelial angiogenesis.

Authors:  Raghu Adya; Bee K Tan; Harpal S Randeva
Journal:  J Diabetes Res       Date:  2015-01-15       Impact factor: 4.011

Review 8.  Adiponectin as a potential biomarker of vascular disease.

Authors:  Mehrangiz Ebrahimi-Mamaeghani; Somayeh Mohammadi; Seyed Rafie Arefhosseini; Parviz Fallah; Zahra Bazi
Journal:  Vasc Health Risk Manag       Date:  2015-01-16

9.  Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase 9 expression in vascular smooth muscle cells.

Authors:  Maryam Saneipour; Keihan Ghatreh-Samani; Esfandiar Heydarian; Effat Farrokhi; Narges Abdian
Journal:  ARYA Atheroscler       Date:  2015-05

Review 10.  Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences.

Authors:  Mieczysław Litwin; Jacek Michałkiewicz; Lidia Gackowska
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.